You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
瑞普生物(300119.SZ)業績快報:2020年淨利升104.88%至3.98億元
格隆匯 03-01 11:53

格隆匯3月1日丨瑞普生物(300119.SZ)披露2020年度業績快報,報吿期內,公司實現營業收入20.00億元,比上年同期增長36.40%;營業利潤5.13億元,同比增長95.05%;利潤總額5.11億元,同比增增長96.57%;歸屬於上市公司股東的淨利潤3.98億元,同比增增長104.88%;歸屬於上市公司股東的扣除非經常性損益的淨利潤為2.85億元,同比增增長約161.48%;基本每股收益為1.0055元,同比增增長105.46%。

報吿期內,國內畜禽養殖行業集中度持續大幅提升,集團化養殖企業出於快速擴張過程中對動物健康養殖及疾病防控的需求,對生物安全體系、疫苗獸藥品質、疫病解決方案、食品安全等提出了更高的要求。公司憑藉疫苗、高端藥品、系列替抗產品、功能添加劑等全面的產品線,以及流行病學監測預警平台、快速響應及技術行銷服務模式,堅持貫徹“以客户為中心”的服務理念,為客户提供全方位的產品加技術支持,帶動了公司產品市場覆蓋率、客户佔有率、品牌認可度的不斷提升,拉動了公司收入的持續高增長。

報吿期內,公司利潤的大幅增長得益於產品營銷結構的改善及產能的釋放,其中豬用疫苗等高毛利產品收入大幅提升,規模效應釋放明顯。同時,公司進行一系列戰略變革,內部效率提高,堅持推行“極致高質量、極致低成本”戰略,促使公司淨利潤率與淨資產收益率的穩步提升。

報吿期末,公司總資產38.99億元,比期初增長9.42%;歸屬於上市公司股東的所有者權益24.56億元,比期初增長15.72%;歸屬於上市公司股東的每股淨資產6.0707元,比期初增長15.72%。公司資產負債率為29.80%,財務狀況良好,財務風險較低。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account